Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Capital Allocation Update

24 Mar 2025 07:00

RNS Number : 8323B
Oakley Capital Investments Limited
24 March 2025
 

24 March 2025

Oakley Capital Investments Limited

Capital Allocation Update and Annual Share Buyback

Oakley Capital Investments Limited1 ("OCI" or the "Company") today announces a capital allocation update reflecting the Board's focus on maximising shareholder returns over the near and long term. OCI is a listed investment company providing consistent returns in excess of the FTSE All-Share Index by investing in funds managed by Oakley Capital2 ("Oakley"). 

Capital Management

 

Share buyback programme - the Board of OCI is pleased to announce an annual recurring share buyback programme of a minimum of £20 million3. The decision reflects the Board's confidence in the Net Asset Value and its belief that the shares are grossly undervalued. It follows a long-term track record of share buybacks, with OCI having acquired and cancelled £72 million of shares since 2019.

 

Dividend policy - given the nominal level of the annual dividend, which is unchanged since its introduction in 2016 and the fact that OCI does not generate sufficient income to support one, the decision has been taken to cancel the dividend in favour of share buybacks. This will take effect in 2025 and will not affect the declared final dividend in respect of the year ended 31 December 2024.

 

New fund commitment - OCI announces a €500 million commitment (£420 million) to Oakley Capital VI, which closed at its hard cap of €4.5 billion. The commitment is expected to be deployed over five years, with the first significant capital drawdown not anticipated to take place until 2026. Fund VI will follow the same strategy as Oakley Capital V, which is currently c.70% deployed, investing in mid-market, founder-led, private European businesses across four core sectors of Technology, Digital Consumer, Education and Business Services. To date, this strategy has delivered total realised returns of 3.9x Gross MM and 52% average realised Gross IRR since inception across all funds.

 

Read Oakley Capital's press release on Oakley Capital Fund VI here.

 

Cash & Commitments

 

Balance sheet OCI's total liquidity at 31 December 2024 was £225 million, comprising £103 million of cash and £122 million in undrawn credit facility. The Company is in advanced discussions to refinance the existing credit facility with one of greater capacity and tenure.

 

Total outstanding commitments - Outstanding Oakley Fund4 commitments now total £1,075 million, of which c.£300 million is not likely to be drawn. This is expected to be deployed into new investments over the next c.5 years.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

 

Greenbrook Communications Limited

+44 20 7952 2000

Rob White / Michael Russell

 

Deutsche Numis (Financial Adviser & Broker)

+44 20 7260 1000

Nathan Brown / Matt Goss

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

1 About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/. The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

2 Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network. The Board has authorised the purchase of ordinary shares in the capital of the Company ("Ordinary Shares") up to an aggregate consideration of £20 million. Shareholders should be aware that (i) the Board retains absolute discretion as to the execution, pricing and timing of any share buybacks, subject to the conditions set out in the authority to execute share buybacks approved at the 2024 annual general meeting; (ii) a repurchase of Ordinary Shares on any trading day may represent a significant proportion of the daily trading volume and could exceed 25 per cent of the average daily trading volume of the preceding 20 business days. The Company has 176,418,438 Ordinary Shares in issue and admitted to trading on the Specialist Fund Segment of the London Stock Exchange with none held in treasury. Ordinary Shares purchased by the Company will be cancelled.

3 Share buyback programme

The Board has authorised the purchase of ordinary shares in the capital of the Company ("Ordinary Shares") up to an aggregate consideration of £20 million. Shareholders should be aware that (i) the Board retains absolute discretion as to the execution, pricing and timing of any share buybacks, subject to the conditions set out in the authority to execute share buybacks approved at the 2024 annual general meeting; (ii) a repurchase of Ordinary Shares on any trading day may represent a significant proportion of the daily trading volume and could exceed 25 per cent of the average daily trading volume of the preceding 20 business days. The Company has 176,418,438 Ordinary Shares in issue and admitted to trading on the Specialist Fund Segment of the London Stock Exchange with none held in treasury. Ordinary Shares purchased by the Company will be cancelled.

4 The Oakley Funds

Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V, Oakley Capital VI, Oakley Capital Origin Fund and Oakley Capital Origin II are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

This announcement may include "forward-looking statements". These forward-looking statements are statements regarding the Company's objectives, intentions, beliefs or current expectations with respect to, amongst other things, the Company's financial position, business strategy, results of operations, liquidity, prospects and growth. Forward-looking statements are subject to risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Accordingly the Company's actual future financial results, operational performance and achievements may differ materially from those expressed in, or implied by, the statements. Given these uncertainties, prospective investors are cautioned not to place any undue reliance on such forward-looking statements, which speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the Company's expectations with regard to them or any change in events, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Regulation Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFEIVDIVFIE
Date   Source Headline
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation
25th Jan 20237:00 amRNSTrading update for the year ended 31 December 2022
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20232:15 pmEQSHardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
15th Dec 20227:00 amRNSOCI commits EUR 30m to Oakley PROfounders III
29th Nov 20227:30 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): Evolution of the high-growth drivers in 2023
10th Nov 20224:17 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.